134 related articles for article (PubMed ID: 24186594)
1. Interferon alpha and rapamycin inhibit the growth of pheochromocytoma PC12 line in vitro.
Motylewska E; Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Niedziela A; Melen-Mucha G; Stepien H
Endokrynol Pol; 2013; 64(5):368-74. PubMed ID: 24186594
[TBL] [Abstract][Full Text] [Related]
2. Interferon alpha and rapamycin inhibit the growth of carcinoid and medullary thyroid cancer in vitro.
Motylewska E; Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Niedziela A; Melen-Mucha G; Stepien H
Pharmacol Rep; 2014 Aug; 66(4):624-9. PubMed ID: 24948064
[TBL] [Abstract][Full Text] [Related]
3. Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model.
Denorme M; Yon L; Roux C; Gonzalez BJ; Baudin E; Anouar Y; Dubessy C
Cancer Lett; 2014 Oct; 352(2):236-44. PubMed ID: 25016061
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of autophagy enhances sunitinib-induced cytotoxicity in rat pheochromocytoma PC12 cells.
Ikeda T; Ishii KA; Saito Y; Miura M; Otagiri A; Kawakami Y; Shimano H; Hara H; Takekoshi K
J Pharmacol Sci; 2013; 121(1):67-73. PubMed ID: 23269235
[TBL] [Abstract][Full Text] [Related]
6. The dual mTORC1 and mTORC2 inhibitor PP242 shows strong antitumor activity in a pheochromocytoma PC12 cell tumor model.
Zhang X; Wang X; Qin L; Xu T; Zhu Z; Zhong S; Zhang M; Shen Z
Urology; 2015 Jan; 85(1):273.e1-7. PubMed ID: 25440763
[TBL] [Abstract][Full Text] [Related]
7. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors.
Zielke A; Middeke M; Hoffmann S; Colombo-Benkmann M; Barth P; Hassan I; Wunderlich A; Hofbauer LC; Duh QY
Surgery; 2002 Dec; 132(6):1056-63; discussion 1063. PubMed ID: 12490855
[TBL] [Abstract][Full Text] [Related]
8. PDK1 Inhibitor GSK-470 Exhibits Potent Anticancer Activity in a Pheochromocytoma PC12 Cell Tumor Model via Akt/mTOR Pathway.
Zhang X; Zhong S
Anticancer Agents Med Chem; 2020; 20(7):828-833. PubMed ID: 32188393
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory Effect of the Noncamptothecin Topoisomerase I Inhibitor LMP-400 on Female Mice Models and Human Pheochromocytoma Cells.
Schovanek J; Bullova P; Tayem Y; Giubellino A; Wesley R; Lendvai N; Nölting S; Kopacek J; Frysak Z; Pommier Y; Kummar S; Pacak K
Endocrinology; 2015 Nov; 156(11):4094-104. PubMed ID: 26267380
[TBL] [Abstract][Full Text] [Related]
10. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects.
Abdollahi A; Lipson KE; Sckell A; Zieher H; Klenke F; Poerschke D; Roth A; Han X; Krix M; Bischof M; Hahnfeldt P; Grone HJ; Debus J; Hlatky L; Huber PE
Cancer Res; 2003 Dec; 63(24):8890-8. PubMed ID: 14695206
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in pheochromocytoma (PC12) cells exposed to eicosapentaenoic acid in vitro.
Li M; Ge H; Kong X; Zheng W; Liu Z
Indian J Biochem Biophys; 2005 Aug; 42(4):222-7. PubMed ID: 23923545
[TBL] [Abstract][Full Text] [Related]
12. Propofol Prevents the Progression of Malignant Pheochromocytoma In Vitro and In Vivo.
Wang H; Zhang S; Zhang A; Yan C
DNA Cell Biol; 2018 Apr; 37(4):308-315. PubMed ID: 29565198
[TBL] [Abstract][Full Text] [Related]
13. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effect of suramin on primary cultures of human pheochromocytomas and rat PC12 pheochromocytoma cells.
Zielke A; Wong MG; Siperstein AE; Clark OH; Rothmund M; Duh QY
J Surg Oncol; 1997 Sep; 66(1):11-8. PubMed ID: 9290687
[TBL] [Abstract][Full Text] [Related]
15. [Antiangiogenic therapy of malignant pheochromocytoma and paraganglioma with the view to the recent scientific developments].
Kukla U; Łabuzek K; Chronowska J; Bobrzyk M; Madej P; Okopień B
Pol Merkur Lekarski; 2015 Apr; 38(226):191-5. PubMed ID: 25938384
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors.
Favier J; Plouin PF; Corvol P; Gasc JM
Am J Pathol; 2002 Oct; 161(4):1235-46. PubMed ID: 12368197
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
18. NICD inhibits cell proliferation and promotes apoptosis and autophagy in PC12 cells.
Li B; Duan P; Han X; Yan W; Xing Y
Mol Med Rep; 2017 Sep; 16(3):2755-2760. PubMed ID: 28677782
[TBL] [Abstract][Full Text] [Related]
19. Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001).
Druce MR; Kaltsas GA; Fraenkel M; Gross DJ; Grossman AB
Horm Metab Res; 2009 Sep; 41(9):697-702. PubMed ID: 19424940
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib Alone and in Combination With Salinosporamid A Induces Apoptosis and Promotes Pheochromocytoma Cell Death In Vitro and in Female Nude Mice.
Bullova P; Cougnoux A; Marzouca G; Kopacek J; Pacak K
Endocrinology; 2017 Oct; 158(10):3097-3108. PubMed ID: 28938421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
